Streptococcus pneumoniae, type 3, lysate
92129-73-2
|
L-Type Calcium Channel Blocker
387350-81-4
|
Danishefsky-type diene
71735-01-8
|
Mucopolysaccharidosis Type II Related CoMpound MPS-II-3 (IdS-IS)
1262147-39-6
|
Flavonoids, lignan-type, Silybum marianum
85865-73-2
|
Bifenazate-diazene
149878-40-0
|
Pt EA solution type CC
68133-90-4
|
didodecyl N-(3-carboxypropanoyl)-L-glutamate
140161-56-4
|
Dodecylbenzenesulphonic acid
27176-87-0
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
Ethyl 3-(4-bromophenyl)-1-methylpyrrolidine-3-carboxylate
2007909-64-8
|
5-(1-Methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridine-2-carboxylic acid
2060593-60-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
rac-[(2R,5S)-5-tert-butyloxolan-2-yl]methanamine
2126143-85-7
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
